JP2016506775A - Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム - Google Patents

Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム Download PDF

Info

Publication number
JP2016506775A
JP2016506775A JP2015552868A JP2015552868A JP2016506775A JP 2016506775 A JP2016506775 A JP 2016506775A JP 2015552868 A JP2015552868 A JP 2015552868A JP 2015552868 A JP2015552868 A JP 2015552868A JP 2016506775 A JP2016506775 A JP 2016506775A
Authority
JP
Japan
Prior art keywords
controller
insulin
subject
model
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015552868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016506775A5 (https=
Inventor
ドイル，フランシス，ジェイ，ザ・サード
ダッソウ，イーヤル
セボーグ，デール，イー
リー，ジューン，ブック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California San Diego UCSD filed Critical University of California
Publication of JP2016506775A publication Critical patent/JP2016506775A/ja
Publication of JP2016506775A5 publication Critical patent/JP2016506775A5/ja
Priority to JP2018228853A priority Critical patent/JP6914907B2/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015552868A 2013-01-14 2014-01-13 Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム Withdrawn JP2016506775A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018228853A JP6914907B2 (ja) 2013-01-14 2018-12-06 Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751941P 2013-01-14 2013-01-14
US61/751,941 2013-01-14
PCT/US2014/011360 WO2014110538A1 (en) 2013-01-14 2014-01-13 Model-based personalization scheme of an artificial pancreas for type i diabetes applications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018228853A Division JP6914907B2 (ja) 2013-01-14 2018-12-06 Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム

Publications (2)

Publication Number Publication Date
JP2016506775A true JP2016506775A (ja) 2016-03-07
JP2016506775A5 JP2016506775A5 (https=) 2018-05-24

Family

ID=51167293

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015552868A Withdrawn JP2016506775A (ja) 2013-01-14 2014-01-13 Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム
JP2018228853A Active JP6914907B2 (ja) 2013-01-14 2018-12-06 Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018228853A Active JP6914907B2 (ja) 2013-01-14 2018-12-06 Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム

Country Status (7)

Country Link
US (4) US10413664B2 (https=)
EP (1) EP2943149B1 (https=)
JP (2) JP2016506775A (https=)
KR (1) KR102211352B1 (https=)
AU (1) AU2014205120B2 (https=)
CA (1) CA2897189C (https=)
WO (2) WO2014109898A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019055258A (ja) * 2013-01-14 2019-04-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
WO2009049252A1 (en) 2007-10-10 2009-04-16 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9292010B2 (en) * 2012-11-05 2016-03-22 Rockwell Automation Technologies, Inc. Online integration of model-based optimization and model-less control
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
CN104749954B (zh) * 2015-02-08 2017-04-12 北京化工大学 基于内模控制策略的智能灰箱控制系统装置及控制方法
CN111905188B (zh) 2015-02-18 2022-07-22 英赛罗公司 流体输送和输注装置及其使用方法
US10275573B2 (en) 2016-01-13 2019-04-30 Bigfoot Biomedical, Inc. User interface for diabetes management system
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
CA3037432A1 (en) 2016-12-12 2018-06-21 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3568860B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP4708311A2 (en) 2017-01-13 2026-03-11 Insulet Corporation Insulin delivery methods, systems and devices
EP3398558A1 (en) 2017-05-02 2018-11-07 Carlo Andretta In body perfusion system
CA3198598A1 (en) 2017-05-05 2018-11-08 Eli Lilly And Company Closed loop control of physiological glucose
EP3438858A1 (en) 2017-08-02 2019-02-06 Diabeloop Closed-loop blood glucose control systems and methods
WO2019125932A1 (en) 2017-12-21 2019-06-27 Eli Lilly And Company Closed loop control of physiological glucose
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
EP3788628B1 (en) 2018-05-04 2024-12-11 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
CN112313754A (zh) 2018-06-22 2021-02-02 伊莱利利公司 胰岛素和普兰林肽输送系统、方法和设备
US11147922B2 (en) * 2018-07-13 2021-10-19 Iowa State University Research Foundation, Inc. Feedback predictive control approach for processes with time delay in the manipulated variable
CN109116738B (zh) * 2018-09-27 2021-04-13 杭州电子科技大学 一种工业加热炉的二自由度内模控制分析方法
US11628251B2 (en) 2018-09-28 2023-04-18 Insulet Corporation Activity mode for artificial pancreas system
EP3864668A1 (en) 2018-10-11 2021-08-18 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
KR102788429B1 (ko) 2019-05-02 2025-03-27 삼성전자주식회사 개인화된 생체 정보 보정 장치 및 방법
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
WO2021113647A1 (en) 2019-12-06 2021-06-10 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
JP7512395B2 (ja) 2020-01-06 2024-07-08 インスレット コーポレイション 持続する残差に基づく食事および／または運動行為の予測
US12370307B2 (en) 2020-02-03 2025-07-29 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
WO2022020197A1 (en) 2020-07-22 2022-01-27 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
WO2022072332A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
EP4221588A1 (en) 2020-09-30 2023-08-09 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
CN112398401B (zh) * 2020-10-29 2022-03-29 上海大学 一种基于参数失配的低开关频率多步模型预测控制方法
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
EP4305636A1 (en) 2021-03-10 2024-01-17 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US20220331520A1 (en) * 2021-04-20 2022-10-20 Insulet Corporation Automatic drug delivery system for individuals with type-2 diabetes
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US20220351820A1 (en) * 2021-05-01 2022-11-03 Christopher Richard Wilson Method for determining glucose-dependent insulin sensitivity factors
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
US12406760B2 (en) 2021-06-07 2025-09-02 Insulet Corporation Exercise safety prediction based on physiological conditions
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
WO2023049900A1 (en) 2021-09-27 2023-03-30 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
WO2023070245A1 (en) * 2021-10-25 2023-05-04 Medtrum Technologies Inc. Closed-loop artificial pancreas insulin infusion control system
CN116020007B (zh) * 2021-10-25 2025-11-25 上海移宇科技股份有限公司 闭环人工胰腺胰岛素输注控制系统
CN116020006B (zh) * 2021-10-25 2025-12-23 上海移宇科技股份有限公司 闭环人工胰腺胰岛素输注控制系统
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
CN120457493A (zh) 2023-01-06 2025-08-08 英赛罗公司 自动或手动启动的随餐推注输送及随后的自动安全约束放宽

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7806886B2 (en) * 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
US6575905B2 (en) * 2000-09-22 2003-06-10 Knobbe, Lim & Buckingham Method and apparatus for real-time estimation of physiological parameters
AU2001292946A1 (en) * 2000-09-26 2002-04-08 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US8114023B2 (en) * 2006-07-28 2012-02-14 Legacy Emanuel Hospital & Health Center Analyte sensing and response system
US10173006B2 (en) * 2007-06-21 2019-01-08 University Of Virginia Patent Foundation LQG artificial pancreas control system and related method
CN102395310A (zh) * 2009-02-26 2012-03-28 莫尔研究应用有限公司 用于自动监控糖尿病相关治疗的方法以及系统
GR1007310B (el) * 2009-03-09 2011-06-10 Αχιλλεας Τσουκαλης Εμφυτευσιμος βιοαισθητηρας με αυτοματη βαθμονομηση
AU2010239138B2 (en) * 2009-04-20 2016-01-21 University Of Technology, Sydney A method and system for determining a variation in a metabolic function and managing the variation accordingly
EP2435962B1 (en) * 2009-05-29 2023-04-19 University of Virginia Patent Foundation System coordinator and modular architecture for open-loop and closed-loop control of diabetes
US8762070B2 (en) * 2010-02-11 2014-06-24 Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US9907909B2 (en) * 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
WO2014109898A1 (en) * 2013-01-14 2014-07-17 The Regents Of University Of California Model-based personalization scheme of an artificial pancreas for type i diabetes applications

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LOUTSEIKO, MIKHAIL, ET AL.: "Closed-Loop Insulin Delivery Utilizing Pole Placement to Compensate for Delays in Subcutaneous Insul", JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, vol. 5, no. 6, JPN6018002670, 2011, pages 1342 - 1351, ISSN: 0003729184 *
TAGLIAVINI, ALESSIA, DEVELOPMENT AND EVALUATION OF PID CONTROLLERS FOR GLUCOSE CONTROL IN PEOPLE WITH TYPE 1 DIABETES MEL, JPN6018002684, 2012, ISSN: 0003729185 *
VAN HEUSDEN, KLASKE, ET AL.: "Control-Relevant Models for Glucose Control Using A Priori Patient Characteristics", IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, vol. 59, no. 7, JPN6018002685, 2012, pages 1839 - 1849, XP011447497, ISSN: 0003729186, DOI: 10.1109/TBME.2011.2176939 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019055258A (ja) * 2013-01-14 2019-04-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム

Also Published As

Publication number Publication date
KR102211352B1 (ko) 2021-02-03
US20200078516A1 (en) 2020-03-12
KR20150108862A (ko) 2015-09-30
JP2019055258A (ja) 2019-04-11
US20220105270A1 (en) 2022-04-07
EP2943149A1 (en) 2015-11-18
US12102796B2 (en) 2024-10-01
AU2014205120B2 (en) 2019-10-17
EP2943149A4 (en) 2016-08-17
CA2897189A1 (en) 2014-07-17
US20240366873A1 (en) 2024-11-07
JP6914907B2 (ja) 2021-08-04
US20150306314A1 (en) 2015-10-29
AU2014205120A1 (en) 2015-07-23
CA2897189C (en) 2017-09-05
US11197955B2 (en) 2021-12-14
WO2014110538A1 (en) 2014-07-17
WO2014109898A1 (en) 2014-07-17
US10413664B2 (en) 2019-09-17
EP2943149B1 (en) 2020-09-30

Similar Documents

Publication Publication Date Title
JP6914907B2 (ja) Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム
Lee et al. Model-based personalization scheme of an artificial pancreas for type 1 diabetes applications
Marchetti et al. A feedforward–feedback glucose control strategy for type 1 diabetes mellitus
JP6810989B2 (ja) １型糖尿病用の人工膵臓のためのモデル予測制御問題における日周目標範囲調節
Palerm et al. A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes
US7651845B2 (en) Method and apparatus for glucose control and insulin dosing for diabetics
JP5183736B2 (ja) Ｌｑｇ人工膵臓制御システム及び関連方法
AU2018388898A1 (en) Closed loop control of physiological glucose
CN112313754A (zh) 胰岛素和普兰林肽输送系统、方法和设备
CN108261591A (zh) 一种人工胰腺的闭环控制算法
Asadi et al. Adaptive fuzzy integral sliding mode control of blood glucose level in patients with type 1 diabetes: In silico studies
CN110352460A (zh) 人工胰腺
Boiroux et al. Overnight control of blood glucose in people with type 1 diabetes
Boiroux et al. Assessment of model predictive and adaptive glucose control strategies for people with type 1 diabetes
Kaveh et al. Higher order sliding mode control for blood glucose regulation
Ottavian et al. Adaptive blood glucose control for intensive care applications
Sejersen et al. Initial titration for people with type 1 diabetes using an artificial pancreas
Langholz et al. Fully automated bi-hormonal intraperitoneal artificial pancreas using a two-layer pid control scheme
Rubb et al. Glucose control in type I diabetic patients: A Volterra model-based approach
El Hachimi et al. Overcoming control challenges in the artificial pancreas
El Hachimi et al. Control algorithm of artificial pancreas systems-a review
Moitra et al. Event Triggered Hybrid Backstepping Controller for Artificial Pancreas
Jallon et al. Personalization of a compartmental physiological model for an artificial pancreas through integration of patient's state estimation
Hachimi et al. Accelerated model predictive controller for artificial pancreas

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180130

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20180405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181002

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20181207